{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T21:52:32Z","timestamp":1778104352043,"version":"3.51.4"},"reference-count":67,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jcardioanesthesia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1053\/j.jvca.2024.11.020","type":"journal-article","created":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T23:22:23Z","timestamp":1732663343000},"page":"818-835","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Analysis of The 2024 ESC\/EACTS Guidelines For The Management Of Atrial Fibrillation"],"prefix":"10.1053","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4908-9774","authenticated-orcid":false,"given":"Juan G.","family":"Ripoll","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marvin G.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward A.","family":"Bittner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamel","family":"Ortoleva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryna","family":"Khromava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek T.","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily K.","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan C.","family":"Diaz Soto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick M.","family":"Wieruszewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kitae","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph S.","family":"Nabzdyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8785-5092","authenticated-orcid":false,"given":"Harish","family":"Ramakrishna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.jvca.2024.11.020_bib0001","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1053\/j.jvca.2024.11.020_bib0002","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1136\/heartjnl-2016-310406","article-title":"Gender differences in clinical presentation and 1-year outcomes in atrial fibrillation","volume":"103","author":"Schnabel","year":"2017","journal-title":"Heart"},{"key":"10.1053\/j.jvca.2024.11.020_bib0003","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1093\/europace\/euz300","article-title":"Sex-related differences in risk factors, outcome, and quality of life in patients with permanent atrial fibrillation: Results from the RACE II study","volume":"22","author":"Kloosterman","year":"2020","journal-title":"Europace"},{"key":"10.1053\/j.jvca.2024.11.020_bib0004","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/europace\/eut395","article-title":"The European Heart Rhythm Association symptom classification for atrial fibrillation: Validation and improvement through a simple modification","volume":"16","author":"Wynn","year":"2014","journal-title":"Europace"},{"key":"10.1053\/j.jvca.2024.11.020_bib0005","doi-asserted-by":"crossref","first-page":"i4482","DOI":"10.1136\/bmj.i4482","article-title":"Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: Systematic review and meta-analysis","volume":"354","author":"Odutayo","year":"2016","journal-title":"BMJ"},{"key":"10.1053\/j.jvca.2024.11.020_bib0006","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1177\/2047487317715769","article-title":"Atrial fibrillation and the risk for myocardial infarction, all-cause mortality and heart failure: A systematic review and meta-analysis","volume":"24","author":"Ruddox","year":"2017","journal-title":"Eur J Prev Cardiol"},{"key":"10.1053\/j.jvca.2024.11.020_bib0007","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191592","article-title":"Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation","volume":"13","author":"Bassand","year":"2018","journal-title":"PLoS One"},{"key":"10.1053\/j.jvca.2024.11.020_bib0008","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1093\/eurheartj\/ehw233","article-title":"Two-year outcomes of patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF","volume":"37","author":"Bassand","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1053\/j.jvca.2024.11.020_bib0009","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1093\/europace\/euac003","article-title":"Predictive role of atrial fibrillation in cognitive decline: A systematic review and meta-analysis of 2.8 million individuals","volume":"24","author":"Koh","year":"2022","journal-title":"Europace"},{"key":"10.1053\/j.jvca.2024.11.020_bib0010","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.025653","article-title":"Atrial fibrillation and the risk of early-onset dementia: A systematic review and meta-analysis","volume":"11","author":"Giannone","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1053\/j.jvca.2024.11.020_bib0011","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1038\/s41591-024-03049-9","article-title":"Thromboembolic events and vascular dementia in patients with atrial fibrillation and low apparent stroke risk","volume":"30","author":"Mobley","year":"2024","journal-title":"Nat Med"},{"key":"10.1053\/j.jvca.2024.11.020_bib0012","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/eurheartj\/ehz666","article-title":"Nurse-led vs. usual-care for atrial fibrillation","volume":"41","author":"Wijtvliet","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1053\/j.jvca.2024.11.020_bib0013","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/j.amjcard.2012.07.011","article-title":"Factors associated with the epidemic of hospitalizations due to atrial fibrillation","volume":"110","author":"Wong","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1053\/j.jvca.2024.11.020_bib0014","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/ehjqcco\/qcaa061","article-title":"Global, regional, and national prevalence, incidence, mortality, and risk factors for atrial fibrillation, 1990-2017: Results from the Global Burden of Disease Study 2017","volume":"7","author":"Dai","year":"2021","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"10.1053\/j.jvca.2024.11.020_bib0015","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1182\/bloodadvances.2020003560","article-title":"Bleeding and related mortality with NOACs and VKAs in newly diagnosed atrial fibrillation: Results from the GARFIELD-AF registry","volume":"5","author":"Bassand","year":"2021","journal-title":"Blood Adv"},{"key":"10.1053\/j.jvca.2024.11.020_bib0016","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1053\/j.jvca.2024.11.020_bib0017","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/nuf.12770","article-title":"Nurses' knowledge of anticoagulation therapy for atrial fibrillation patients: Effectiveness of an educational course","volume":"57","author":"Omoush","year":"2022","journal-title":"Nurs Forum"},{"key":"10.1053\/j.jvca.2024.11.020_bib0018","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1093\/eurheartj\/ehaa421","article-title":"STEEER-AF: A cluster-randomized education trial from the ESC","volume":"41","author":"Bunting","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1053\/j.jvca.2024.11.020_bib0019","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/S0140-6736(17)32165-7","article-title":"A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): An international, cluster-randomised trial","volume":"390","author":"Vinereanu","year":"2017","journal-title":"Lancet"},{"key":"10.1053\/j.jvca.2024.11.020_bib0020","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euy067","article-title":"Sex differences in cardiac arrhythmia: A consensus document of the European Heart Rhythm Association, endorsed by the Heart Rhythm Society and Asia Pacific Heart Rhythm Society","volume":"20","author":"Linde","year":"2018","journal-title":"Europace"},{"key":"10.1053\/j.jvca.2024.11.020_bib0021","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002950","article-title":"An integrated management approach to atrial fibrillation","volume":"5","author":"Carter","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1053\/j.jvca.2024.11.020_bib0022","doi-asserted-by":"crossref","first-page":"e88131","DOI":"10.1371\/journal.pone.0088131","article-title":"Systematic review of observational studies assessing bleeding risk in patients with atrial fibrillation not using anticoagulants","volume":"9","author":"Lopes","year":"2014","journal-title":"PLoS One"},{"key":"10.1053\/j.jvca.2024.11.020_bib0023","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/eurjhf\/hft004","article-title":"Predictors and prognostic implications of incident heart failure following the first diagnosis of atrial fibrillation in patients with structurally normal hearts: The Belgrade Atrial Fibrillation Study","volume":"15","author":"Potpara","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1053\/j.jvca.2024.11.020_bib0024","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003599","article-title":"Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: An individual participant data meta-analysis","volume":"18","author":"Pinho-Gomes","year":"2021","journal-title":"PLoS Med"},{"key":"10.1053\/j.jvca.2024.11.020_bib0025","article-title":"2024 ESC Guidelines for the Management of Elevated Blood Pressure and Hypertension: What is new in pharmacotherapy?","author":"McCarthy","year":"2024","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1053\/j.jvca.2024.11.020_bib0026","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1161\/CIRCULATIONAHA.114.010999","article-title":"Central sympathetic inhibition to reduce postablation atrial fibrillation recurrences in hypertensive patients: A randomized, controlled study","volume":"130","author":"Giannopoulos","year":"2014","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2024.11.020_bib0027","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.jacc.2010.01.043","article-title":"Prevention of atrial fibrillation by the renin-angiotensin system inhibition a meta-analysis","volume":"55","author":"Schneider","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2024.11.020_bib0028","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.ijcard.2015.10.220","article-title":"Atrial fibrillation and heart failure due to reduced versus preserved ejection fraction: A systematic review and meta-analysis of death and adverse outcomes","volume":"203","author":"Kotecha","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1053\/j.jvca.2024.11.020_bib0029","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12933-021-01423-2","article-title":"Association of diabetes with atrial fibrillation types: A systematic review and meta-analysis","volume":"20","author":"Alijla","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"10.1053\/j.jvca.2024.11.020_bib0030","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejim.2022.04.026","article-title":"Impact of diabetes on the management and outcomes in atrial fibrillation: An analysis from the ESC-EHRA EORP-AF Long-Term General Registry","volume":"103","author":"Ding","year":"2022","journal-title":"Eur J Intern Med"},{"key":"10.1053\/j.jvca.2024.11.020_bib0031","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1093\/eurheartj\/ehad192","article-title":"2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes","volume":"44","author":"Marx","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1053\/j.jvca.2024.11.020_bib0032","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jacep.2019.03.005","article-title":"Variability of sleep apnea severity and risk of atrial fibrillation: The VARIOSA-AF study","volume":"5","author":"Linz","year":"2019","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1053\/j.jvca.2024.11.020_bib0033","article-title":"Personalized management of sleep apnea in patients with atrial fibrillation: An interdisciplinary and translational challenge","volume":"35","author":"Linz","year":"2021","journal-title":"Int J Cardiol Heart Vasc"},{"key":"10.1053\/j.jvca.2024.11.020_bib0034","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jacep.2015.04.004","article-title":"Obesity and the risk of incident, post-operative, and post-ablation atrial fibrillation: A meta-analysis of 626,603 individuals in 51 studies","volume":"1","author":"Wong","year":"2015","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1053\/j.jvca.2024.11.020_bib0035","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/HCR.0000000000000665","article-title":"Effects of supervised exercise training on atrial fibrillation: A meta-analysis of randomized controlled trials","volume":"42","author":"Oesterle","year":"2022","journal-title":"J Cardiopulm Rehabil Prev"},{"key":"10.1053\/j.jvca.2024.11.020_bib0036","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1093\/europace\/euaa340","article-title":"Effect of alcohol consumption on the risk of adverse events in atrial fibrillation: From the COmparison study of Drugs for symptom control and complication prEvention of Atrial Fibrillation (CODE-AF) registry","volume":"23","author":"Lim","year":"2021","journal-title":"Europace"},{"key":"10.1053\/j.jvca.2024.11.020_bib0037","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1817591","article-title":"Alcohol abstinence in drinkers with atrial fibrillation","volume":"382","author":"Voskoboinik","year":"2020","journal-title":"N Engl J Med"},{"issue":"1 Pt C","key":"10.1053\/j.jvca.2024.11.020_bib0038","article-title":"Atrial fibrillation and stroke: State-of-the-art and future directions","volume":"49","author":"Elsheikh","year":"2024","journal-title":"Curr Probl Cardiol"},{"key":"10.1053\/j.jvca.2024.11.020_bib0039","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1080\/07853890.2016.1179390","article-title":"Predictive role of CHADS2 and CHA2DS2-VASc scores on stroke and thromboembolism in patients without atrial fibrillation: A meta-analysis","volume":"48","author":"Liu","year":"2016","journal-title":"Ann Med"},{"key":"10.1053\/j.jvca.2024.11.020_bib0040","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1093\/eurheartj\/ehae540","article-title":"CHA2DS2-VASc or a non-sex score (CHA2DS2-VA) for stroke risk prediction in atrial fibrillation: Contemporary insights and clinical implications","volume":"45","author":"Lip","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1053\/j.jvca.2024.11.020_bib0041","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1055\/s-0043-1776394","article-title":"Sex as a risk factor for atrial fibrillation-related stroke","volume":"124","author":"Corica","year":"2024","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.jvca.2024.11.020_bib0042","article-title":"Comparing CHA2DS2-VA and CHA2DS2-VASc scores for stroke risk stratification in patients with atrial fibrillation: A temporal trends analysis from the retrospective Finnish AntiCoagulation in Atrial Fibrillation (FinACAF) cohort","volume":"43","author":"Teppo","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"10.1053\/j.jvca.2024.11.020_bib0043","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1093\/eurheartj\/ehae539","article-title":"Gender and contemporary risk of adverse events in atrial fibrillation","volume":"45","author":"Champsi","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1053\/j.jvca.2024.11.020_bib0044","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1161\/CIRCULATIONAHA.121.056355","article-title":"Direct oral anticoagulants versus warfarin in patients with atrial fibrillation: Patient-level network meta-analyses of randomized clinical trials with interaction testing by age and sex","volume":"145","author":"Carnicelli","year":"2022","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2024.11.020_bib0045","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1056\/NEJMoa1300615","article-title":"Dabigatran versus warfarin in patients with mechanical heart valves","volume":"369","author":"Eikelboom","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2024.11.020_bib0046","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2300067","article-title":"Apixaban or warfarin in patients with an on-X mechanical aortic valve","volume":"2","author":"Wang","year":"2023","journal-title":"NEJM Evid"},{"key":"10.1053\/j.jvca.2024.11.020_bib0047","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1056\/NEJMoa2101897","article-title":"Left atrial appendage occlusion during cardiac surgery to prevent stroke","volume":"384","author":"Whitlock","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2024.11.020_bib0048","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1053\/j.jvca.2021.05.011","article-title":"Analysis of the ESC\/EACTS 2020 atrial fibrillation guidelines with perioperative implications","volume":"36","author":"Nelson","year":"2022","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2024.11.020_bib0049","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1053\/j.jvca.2020.07.034","article-title":"The convergent procedure: A unique multidisciplinary hybrid treatment of atrial fibrillation","volume":"35","author":"Trzcinka","year":"2021","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2024.11.020_bib0050","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: A report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2024.11.020_bib0051","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1056\/NEJMoa2306037","article-title":"Catheter ablation in end-stage heart failure with atrial fibrillation","volume":"389","author":"Sohns","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2024.11.020_bib0052","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165790","article-title":"Patient-reported outcomes for quality of life assessment in atrial fibrillation: A systematic review of measurement properties","volume":"11","author":"Kotecha","year":"2016","journal-title":"PLoS One"},{"key":"10.1053\/j.jvca.2024.11.020_bib0053","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jcrc.2021.11.005","article-title":"Comparative effectiveness of common treatments for new-onset atrial fibrillation within the ICU: Accounting for physiological status","volume":"67","author":"Bedford","year":"2022","journal-title":"J Crit Care"},{"key":"10.1053\/j.jvca.2024.11.020_bib0054","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ijcard.2015.06.094","article-title":"Atrial fibrillation is a risk marker for worse in-hospital and long-term outcome in patients with peripheral artery disease","volume":"199","author":"Wasmer","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1053\/j.jvca.2024.11.020_bib0055","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1056\/NEJMoa2303048","article-title":"Early versus later anticoagulation for stroke with atrial fibrillation","volume":"388","author":"Fischer","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2024.11.020_bib0056","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/CIRCULATIONAHA.122.060666","article-title":"Early versus delayed non-vitamin K antagonist oral anticoagulant therapy after acute ischemic stroke in atrial fibrillation (TIMING): A registry-based randomized controlled noninferiority study","volume":"146","author":"Oldgren","year":"2022","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2024.11.020_bib0057","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S1474-4422(21)00298-2","article-title":"Apixaban versus no anticoagulation after anticoagulation-associated intracerebral haemorrhage in patients with atrial fibrillation in the Netherlands (APACHE-AF): A randomised, open-label, phase 2 trial","volume":"20","author":"Schreuder","year":"2021","journal-title":"Lancet Neurol"},{"key":"10.1053\/j.jvca.2024.11.020_bib0058","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S1474-4422(21)00264-7","article-title":"Effects of oral anticoagulation for atrial fibrillation after spontaneous intracranial haemorrhage in the UK: A randomised, open-label, assessor-masked, pilot-phase, non-inferiority trial","volume":"20","year":"2021","journal-title":"Lancet Neurol"},{"key":"10.1053\/j.jvca.2024.11.020_bib0059","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.017966","article-title":"New-onset atrial fibrillation after coronary artery bypass grafting and long-term outcome: A population-based nationwide study from the SWEDEHEART registry","volume":"10","author":"Taha","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1053\/j.jvca.2024.11.020_bib0060","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/j.amjcard.2017.01.018","article-title":"Outcomes of direct current cardioversion in adults with congenital heart disease","volume":"119","author":"Egbe","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1053\/j.jvca.2024.11.020_bib0061","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(21)01637-8","article-title":"Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): A multicentre, parallel group, unmasked, randomised controlled trial","volume":"398","author":"Svennberg","year":"2021","journal-title":"Lancet"},{"key":"10.1053\/j.jvca.2024.11.020_bib0062","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/S0140-6736(21)01698-6","article-title":"Implantable loop recorder detection of atrial fibrillation to prevent stroke (The LOOP Study): A randomised controlled trial","volume":"398","author":"Svendsen","year":"2021","journal-title":"Lancet"},{"key":"10.1053\/j.jvca.2024.11.020_bib0063","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/08037051.2019.1633905","article-title":"Antihypertensive therapy prevents new-onset atrial fibrillation in patients with isolated systolic hypertension: The LIFE study","volume":"28","author":"Larstorp","year":"2019","journal-title":"Blood Press"},{"key":"10.1053\/j.jvca.2024.11.020_bib0064","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1016\/j.jacc.2004.11.070","article-title":"Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: A meta-analysis","volume":"45","author":"Healey","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2024.11.020_bib0065","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1177\/2047487318782379","article-title":"Individual and combined impact of lifestyle factors on atrial fibrillation in apparently healthy men and women: The EPIC-Norfolk prospective population study","volume":"25","author":"Di Benedetto","year":"2018","journal-title":"Eur J Prev Cardiol"},{"key":"10.1053\/j.jvca.2024.11.020_bib0066","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1136\/bjsports-2021-103994","article-title":"Risk of atrial fibrillation in athletes: A systematic review and meta-analysis","volume":"55","author":"Newman","year":"2021","journal-title":"Br J Sports Med"},{"key":"10.1053\/j.jvca.2024.11.020_bib0067","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12933-020-01105-5","article-title":"SGLT2 inhibitors and atrial fibrillation in type 2 diabetes: A systematic review with meta-analysis of 16 randomized controlled trials","volume":"19","author":"Li","year":"2020","journal-title":"Cardiovasc Diabetol"}],"container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077024009170?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077024009170?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T17:05:00Z","timestamp":1742231100000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053077024009170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":67,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1053077024009170"],"URL":"https:\/\/doi.org\/10.1053\/j.jvca.2024.11.020","relation":{},"ISSN":["1053-0770"],"issn-type":[{"value":"1053-0770","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of The 2024 ESC\/EACTS Guidelines For The Management Of Atrial Fibrillation","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiothoracic and Vascular Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jvca.2024.11.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}